← Insiders

DHR

Bearish signalScored 2026-10-04 Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.

Research, not advice.

À propos

Danaher Corporation

Nom
Danaher Corporation
Secteur
Healthcare
Industrie
Medical - Diagnostics & Research
Bourse
NYSE
Capitalisation
$162.0B
Employés
59,000
PDG
Julie Sawyer Montgomery
Site web
https://www.danaher.com
Marché
ABMXXYBRKRILMNMTDQGEN

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

Decouvert par les declarations du Congres

Insiders
—
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
—

Avg sell (VWAP, 90d window) —

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

Last activity
—
Liquidity
Liquid $974,100,016/day · 20d vol
Last synced
2026-10-20 00:36:23 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

No Form 4 filings for this company in this window.

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent trades

DateRepresentativeTypeAmount
2026-09-02Kevin HernSale (Partial)$1,001 - $15,000
2026-08-31Kevin HernSale (Full)$15,001 - $50,000
2026-06-16Michael T. McCaulPurchase$1,001 - $15,000
2026-06-05Michael T. McCaulPurchase$1,001 - $15,000
2026-06-03Michael T. McCaulPurchase$1,001 - $15,000
2026-06-02Michael T. McCaulPurchase$1,001 - $15,000
2026-06-02Ro KhannaPurchase$15,001 - $50,000
2026-04-28Michael T. McCaulPurchase$1,001 - $15,000
2026-03-05Michael T. McCaulPurchase$1,001 - $15,000
2026-01-29Ro KhannaSale$1,001 - $15,000
2025-12-18Julie JohnsonSale (Full)$1,001 - $15,000
2025-11-13Julie JohnsonSale (Partial)$1,001 - $15,000
2025-10-07Julie JohnsonPurchase$1,001 - $15,000
2025-10-03Ro KhannaPurchase$1,001 - $15,000
2025-09-29Ro KhannaSale$15,001 - $50,000
2025-09-25Lisa C. McClainSale (Full)$1,001 - $15,000
2025-09-25Michael T. McCaulPurchase$1,001 - $15,000
2025-09-09Michael T. McCaulPurchase$1,001 - $15,000
2025-09-05Ro KhannaPurchase$1,001 - $15,000
2025-09-03Thomas KeanPurchase$1,001 - $15,000
2025-07-22Lisa C. McClainPurchase$1,001 - $15,000
2025-07-02Ro KhannaSale$1,001 - $15,000
2025-06-30Michael T. McCaulPurchase$1,001 - $15,000
2025-06-26Michael T. McCaulPurchase$15,001 - $50,000
2025-06-20Michael T. McCaulPurchase$50,001 - $100,000
2025-06-12Pete SessionsSale (Full)$50,001 - $100,000
2025-06-11Thomas KeanPurchase$1,001 - $15,000
2025-05-15Robert P. BresnahanSale (Full)$1,001 - $15,000
2025-05-12Jefferson ShreveSale (Full)$15,001 - $50,000
2025-04-28Julia LetlowPurchase$1,001 - $15,000
2025-04-21Bruce WestermanSale (Full)$1,001 - $15,000
2025-04-11Daniel Milton NewhouseSale (Partial)$1,001 - $15,000
2025-04-08Robert P. BresnahanPurchase$15,001 - $50,000
2025-04-07Jefferson ShreveSale (Full)$15,001 - $50,000
2025-03-27Greg LandsmanSale (Full)$1,001 - $15,000
2025-03-04Bruce WestermanPurchase$1,001 - $15,000
2025-02-26Gilbert CisnerosSale (Partial)$1,001 - $15,000
2025-02-25Robert P. BresnahanSale (Full)$15,001 - $50,000
2025-01-15Julie JohnsonSale (Full)$1,001 - $15,000
2024-11-01Ro KhannaPurchase$1,001 - $15,000
2024-10-29Val HoylePurchase$1,001 - $15,000
2024-09-09Ro KhannaSale$1,001 - $15,000
2024-06-07Ro KhannaPurchase$1,001 - $15,000
2024-04-10Daniel Milton NewhousePurchase$1,001 - $15,000
2024-02-13Ro KhannaPurchase$1,001 - $15,000
2024-01-10Ro KhannaPurchase$15,001 - $50,000
2023-12-04John R. CurtisSale (Full)$1,001 - $15,000
2023-10-31Ro KhannaSale$15,001 - $50,000
2023-10-26Ro KhannaSale$50,001 - $100,000
2023-10-24Greg StantonSale (Full)$1,001 - $15,000
2023-10-02Ro KhannaPurchase$1,001 - $15,000
2023-09-26Greg StantonPurchase$1,001 - $15,000
2023-08-29Ro KhannaPurchase$1,001 - $15,000
2023-07-31Thomas KeanPurchase$1,001 - $15,000
2023-07-28Ro KhannaPurchase$1,001 - $15,000
2023-07-07Ro KhannaSale$15,001 - $50,000
2023-06-29Ro KhannaPurchase$15,001 - $50,000
2023-06-26Ro KhannaPurchase$15,001 - $50,000
2023-05-25Zoe LofgrenSale (Full)$1,001 - $15,000
2023-05-23Ro KhannaSale$1,001 - $15,000
2023-05-19Ro KhannaSale$50,001 - $100,000
2023-05-05Ro KhannaSale$1,001 - $15,000
2023-05-04Ro KhannaSale$1,001 - $15,000
2023-03-24Ro KhannaSale$1,001 - $15,000
2023-03-14Ro KhannaPurchase$15,001 - $50,000
2023-03-06Daniel GoldmanSale (Partial)$1,001 - $15,000
2023-02-10Ro KhannaPurchase$1,001 - $15,000
2023-02-03Ro KhannaSale$1,001 - $15,000
2023-01-31Kevin HernSale (Full)$1,001 - $15,000
2023-01-09Ro KhannaSale$15,001 - $50,000
2023-01-06Ro KhannaPurchase$1,001 - $15,000
2022-12-06Ro KhannaSale$15,001 - $50,000
2022-12-06Ro KhannaSale$1,001 - $15,000
2022-12-05Ro KhannaSale$1,001 - $15,000
2022-12-01Kurt SchraderSale$1,001 - $15,000
2022-11-03Ro KhannaSale$1,001 - $15,000
2022-10-21Ro KhannaSale$1,001 - $15,000
2022-10-20Ro KhannaSale$1,001 - $15,000
2022-10-12Lois FrankelSale (Full)$1,001 - $15,000
2022-09-29Ro KhannaPurchase$15,001 - $50,000
2022-09-28Lois FrankelSale (Partial)$1,001 - $15,000
2022-09-20Daniel Milton NewhousePurchase$1,001 - $15,000
2022-09-14Lois FrankelSale (Partial)$1,001 - $15,000
2022-09-06Ro KhannaPurchase$1,001 - $15,000
2022-08-23Ro KhannaPurchase$15,001 - $50,000
2022-07-19Ro KhannaPurchase$1,001 - $15,000
2022-07-15Kathy E. ManningPurchase$1,001 - $15,000
2022-06-27Ro KhannaPurchase$1,001 - $15,000
2022-06-17Ro KhannaPurchase$1,001 - $15,000
2022-06-16Ro KhannaSale$50,001 - $100,000
2022-05-23Ro KhannaPurchase$15,001 - $50,000
2022-05-10Ro KhannaSale$15,001 - $50,000
2022-05-06Ro KhannaPurchase$1,001 - $15,000
2022-05-05Ro KhannaSale$1,001 - $15,000
2022-05-05Ro KhannaPurchase$15,001 - $50,000
2022-05-05Ro KhannaSale$15,001 - $50,000
2022-04-20Ro KhannaPurchase$1,001 - $15,000
2022-04-06Ro KhannaSale$1,001 - $15,000
2022-04-06Ro KhannaSale$1,001 - $15,000
2015-05-08Jefferson ShrevePurchase$15,001 - $50,000

Signal

Bearish signalScored 2026-10-04 Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.

DHR presents a solid liquidity foundation (score: 85) that provides a meaningful buffer, but the weak fundamental trend score (45) reflects real deterioration in profitability margins and a stretched valuation that…

The first sentence of the analysis written for DHR on 2026-10-04 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Bearish signal Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Unavailable or mixed. No open-market purchase or sale value stored
  • Congress Pulls against a bullish reading. STOCK Act sale disclosures outnumber purchases
  • Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
  • Timing Supports a bullish reading. Interesting trend — weekly bias up
  • Financial indicators Supports a bullish reading. Current ratio 1.87 · operating margin 21%

Suggested stop 212.41, nearest stored support minus 0.5 ATR(4.0% under the last close). Reward/risk to the next stored resistance is 0.80. Wait — that reward/risk is under 2. Research, not advice. Not an order.

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin60.9%59.5%58.7%60.8%61.0%
Ebit Margin18.3%20.6%22.3%27.6%26.6%
Ebitda Margin28.3%30.5%31.4%35.6%34.0%
Operating Profit Margin20.9%21.7%22.1%28.3%27.3%
Pretax Profit Margin17.2%19.5%21.1%26.8%25.8%
Continuous Operations Profit Margin14.7%16.3%17.7%23.8%21.5%
Net Profit Margin14.7%16.3%19.9%27.1%21.8%
Bottom Line Profit Margin14.7%16.3%19.9%26.7%21.5%
Current Ratio1.8741.3971.6841.8931.431
Quick Ratio1.5081.0541.3711.5641.091
Solvency Ratio0.1960.2230.2240.2730.226
Cash Ratio0.6780.3060.7090.7150.318
Price To Earnings Ratio45.15243.06835.92224.00733.253
Price To Earnings Growth Ratio-9.256-2.499-1.0482.0440.435
Forward Price To Earnings Growth Ratio-9.256-2.499-1.0482.0440.435
Price To Earnings Diluted Ratio45.42143.39336.26024.40633.871
Price To Earnings Diluted Growth Ratio-9.611-2.540-1.0722.0400.445
Price To Book Ratio3.0823.3873.1863.4064.614
Price To Sales Ratio6.5907.0287.1326.4037.076
Price To Free Cash Flow Ratio30.78231.68429.47323.15729.502
Price To Operating Cash Flow Ratio25.23625.09023.78320.02524.934
Debt To Assets Ratio0.2210.2210.2310.2440.280
Debt To Equity Ratio0.3510.3460.3650.4120.515
Debt To Capital Ratio0.2600.2570.2680.2920.340
Long Term Debt To Capital Ratio0.2600.2380.2380.2760.329
Financial Leverage Ratio1.5891.5651.5801.6841.842
Working Capital Turnover Ratio5.6825.7103.6324.8435.945
Operating Cash Flow Ratio0.9430.9840.8661.0151.027
Operating Cash Flow Sales Ratio0.2610.2800.3000.3200.284
Free Cash Flow Operating Cash Flow Ratio0.8200.7920.8070.8650.845
Debt Service Coverage Ratio23.6938.3383.0858.98119.202
Interest Coverage Ratio19.38518.64718.26636.40633.402
Short Term Operating Cash Flow Coverage Ratio3,208.00013.2443.82111.23938.874
Operating Cash Flow Coverage Ratio0.3480.3900.3670.4130.359
Capital Expenditure Coverage Ratio5.5504.8055.1807.3956.459
Dividend Paid And Capex Coverage Ratio3.1543.0963.2504.3244.105
Dividend Payout Ratio0.2430.1970.1720.1130.115
Enterprise Value Multiple25.30125.13324.54419.52722.892

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 60.9% ▲1.4% ▲0.8%
Ebit Margin 18.3% ▼-2.3% ▼-4.8%
Ebitda Margin 28.3% ▼-2.2% ▼-3.7%
Operating Profit Margin 20.9% ▼-0.8% ▼-3.2%
Pretax Profit Margin 17.2% ▼-2.2% ▼-4.9%
Continuous Operations Profit Margin 14.7% ▼-1.6% ▼-4.1%
Net Profit Margin 14.7% ▼-1.6% ▼-5.3%
Bottom Line Profit Margin 14.7% ▼-1.6% ▼-5.1%
Current Ratio 1.874 ▲0.477 ▲0.218
Quick Ratio 1.508 ▲0.454 ▲0.191
Solvency Ratio 0.196 ▼-0.027 ▼-0.032
Cash Ratio 0.678 ▲0.372 ▲0.133
Price To Earnings Ratio 45.152 ▲2.084 ▲8.871
Price To Earnings Growth Ratio -9.256 ▼-6.757 ▼-7.191
Forward Price To Earnings Growth Ratio -9.256 ▼-6.757 ▼-7.191
Price To Earnings Diluted Ratio 45.421 ▲2.027 ▲8.751
Price To Earnings Diluted Growth Ratio -9.611 ▼-7.071 ▼-7.463
Price To Book Ratio 3.082 ▼-0.305 ▼-0.453
Price To Sales Ratio 6.590 ▼-0.438 ▼-0.255
Price To Free Cash Flow Ratio 30.782 ▼-0.902 ▲1.863
Price To Operating Cash Flow Ratio 25.236 ▲0.146 ▲1.423
Debt To Assets Ratio 0.221 ▼-0.000 ▼-0.019
Debt To Equity Ratio 0.351 ▲0.004 ▼-0.047
Debt To Capital Ratio 0.260 ▲0.003 ▼-0.024
Long Term Debt To Capital Ratio 0.260 ▲0.021 ▼-0.009
Financial Leverage Ratio 1.589 ▲0.024 ▼-0.063
Working Capital Turnover Ratio 5.682 ▼-0.029 ▲0.519
Operating Cash Flow Ratio 0.943 ▼-0.041 ▼-0.024
Operating Cash Flow Sales Ratio 0.261 ▼-0.019 ▼-0.028
Free Cash Flow Operating Cash Flow Ratio 0.820 ▲0.028 ▼-0.006
Debt Service Coverage Ratio 23.693 ▲15.354 ▲11.033
Interest Coverage Ratio 19.385 ▲0.737 ▼-5.837
Short Term Operating Cash Flow Coverage Ratio 3208.000 ▲3194.756 ▲2552.965
Operating Cash Flow Coverage Ratio 0.348 ▼-0.042 ▼-0.027
Capital Expenditure Coverage Ratio 5.550 ▲0.746 ▼-0.328
Dividend Paid And Capex Coverage Ratio 3.154 ▲0.058 ▼-0.432
Dividend Payout Ratio 0.243 ▲0.046 ▲0.075
Enterprise Value Multiple 25.301 ▲0.168 ▲1.822

Key metrics

MetricTrend20252024202320222021
Market cap$161.92B$167.80B$170.38B$170.59B$208.40B
Enterprise value$175.72B$182.87B$184.05B$185.22B$229.08B
EV / Sales7.15x7.66x7.70x6.95x7.78x
EV / Op. cash flow27.39x27.34x25.69x21.74x27.41x
EV / Free cash flow33.41x34.53x31.84x25.14x32.43x
EV / EBITDA25.30x25.13x24.54x19.53x22.89x
Net debt / EBITDA1.99x2.07x1.82x1.54x2.07x
Current ratio1.87x1.40x1.68x1.89x1.43x
Income quality1.77x1.72x1.70x1.18x1.32x
Graham number$92$90$103$124$113
Graham net-net-$31-$29-$28-$32-$42
Tax burden85.4%83.9%94.4%100.9%84.7%
Interest burden94.1%94.4%94.6%97.2%96.9%
Working capital$5.95B$2.70B$5.66B$7.49B$3.51B
Invested capital$73.66B$67.84B$73.62B$69.18B$72.37B
Return on assets4.3%5.0%5.6%8.5%7.7%
Operating ROA6.4%6.4%6.3%9.0%10.1%
Return on tangible assets16.1%21.1%21.5%26.5%33.6%
Return on equity6.9%7.9%8.9%14.4%14.2%
Return on invested capital5.7%6.1%5.7%8.7%8.9%
Return on capital employed6.7%7.3%6.9%9.9%10.7%
Earnings yield2.2%2.3%2.8%4.2%3.1%
Free cash flow yield3.2%3.2%3.4%4.3%3.4%
Capex / Op. cash flow18.0%20.8%19.3%13.5%15.5%
Capex / Depreciation47.2%59.2%63.9%54.0%59.7%
Capex / Sales4.7%5.8%5.8%4.3%4.4%
SG&A / Sales33.5%31.2%30.4%26.7%27.7%
R&D / Sales6.5%6.6%6.3%5.7%5.9%
Stock comp / Sales1.2%1.2%1.3%1.1%0.6%
Intangibles / Total assets73.0%76.2%73.8%67.7%77.0%
Days sales outstanding58d67d71d69d67d
Days payables outstanding70d66d65d65d82d
Operating cycle153d155d167d166d155d
Cash conversion cycle83d89d102d101d74d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▼-3.5%EV / Sales ▼-6.6%EV / EBITDA ▲+0.7%EV / Op. cash flow ▲+0.045Earnings yield ▼-0.001Graham number ▲+2.220
Profitability
Return on equity ▼-0.010Return on assets ▼-0.007Return on invested capital ▼-0.004Return on capital employed ▼-0.006Operating ROA -0.000Income quality ▲+0.060Tax burden ▲+0.015
Efficiency
Days sales outstanding ▼-8.980Days payables outstanding ▲+3.950Operating cycle ▼-2.283Cash conversion cycle ▼-6.233Capex / Sales ▼-0.011R&D / Sales ▼-0.001
Balance-sheet strength
Current ratio ▲+0.477Net debt / EBITDA ▼-0.083Working capital ▲+3250000000.000Invested capital ▲+5824000000.000Intangibles / Total assets ▼-0.031

Change over 5 years

Valuation
Market cap ▼-22.3%EV / Sales ▼-8.0%EV / EBITDA ▲+10.5%EV / Op. cash flow ▼-0.022Earnings yield ▼-0.009Graham number ▼-20.741
Profitability
Return on equity ▼-0.074Return on assets ▼-0.034Return on invested capital ▼-0.032Return on capital employed ▼-0.040Operating ROA ▼-0.037Income quality ▲+0.458Tax burden ▲+0.007
Efficiency
Days sales outstanding ▼-9.319Days payables outstanding ▼-11.406Operating cycle ▼-2.480Cash conversion cycle ▲+8.926Capex / Sales ▲+0.003R&D / Sales ▲+0.006
Balance-sheet strength
Current ratio ▲+0.443Net debt / EBITDA ▼-0.080Working capital ▲+2441000000.000Invested capital ▲+1296000000.000Intangibles / Total assets ▼-0.039

Employee count

Peer market caps

Recent news